These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26614005)

  • 21. Efficacy of adalimumab for the treatment of extraintestinal manifestations of Crohn's disease.
    Barreiro-de-Acosta M; Lorenzo A; Domínguez-Muñoz JE
    Rev Esp Enferm Dig; 2012 Sep; 104(9):468-72. PubMed ID: 23130854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
    Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
    World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.
    Veloso FT; Carvalho J; Magro F
    J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
    Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
    Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.
    Siemanowski B; Regueiro M
    Curr Treat Options Gastroenterol; 2007 Jun; 10(3):178-84. PubMed ID: 17547856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral arthritis in the course of inflammatory bowel diseases.
    Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N
    Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    States V; O'Brien S; Rai JP; Roberts HL; Paas M; Feagins K; Pierce EJ; Baumgartner RN; Galandiuk S
    Dig Dis Sci; 2020 Sep; 65(9):2675-2685. PubMed ID: 31925675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
    Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
    Yang BR; Choi NK; Kim MS; Chun J; Joo SH; Kim H; Lee J
    PLoS One; 2018; 13(7):e0200363. PubMed ID: 29990326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
    Ott C; Takses A; Obermeier F; Schnoy E; Müller M
    World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
    Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
    Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.